The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
Abstract
Genome-wide mutational signatures of the group 1 carcinogen aristolochic acid are observed in urothelial cancers and liver cancers from Asia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029 · cited 1×
“In addition, RNA-seq analysis of one tumor-normal pair revealed up-regulation of 13 of 15 NMD pathway genes previously reported to be up-regulated in response to aberrant splicing (26) (P = 0.”
BackgroundMapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
You, J. S., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.008 · Cited by 1,167
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Govindan, R., Ding, L., Griffith, M., Subramanian, J., Dees, N. D., Kanchi, K. L., Maher, C. A., Fulton, R., Fulton, L., Wallis, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.024 · Cited by 1,146
Vanherweghem, J.-L., Tielemans, C., Abramowicz, D., Depierreux, M., Vanhaelen-Fastre, R., Vanhaelen, M., Dratwa, M., Richard, C., Vandervelde, D., Verbeelen, D., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92984-2 · Cited by 1,076
A small-cell lung cancer genome with complex signatures of tobacco exposure
Pleasance, E. D., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A., Jones, D., Lin, M.-L., Beare, D., Lau, K. W., Greenman, C., et al. (2010) · Nature · doi:10.1038/nature08629 · Cited by 1,066
Self-citationThe CORGI Consortium, Palles, C., The WGS500 Consortium, Cazier, J.-B., Howarth, K. M., Domingo, E., Jones, A. M., Broderick, P., Kemp, Z., Spain, S. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2503 · Cited by 997
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
Self-citationUrothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)
Nortier, J. L., Martinez, M.-C. M., Schmeiser, H. H., Arlt, V. M., Bieler, C. A., Petein, M., Depierreux, M. F., De Pauw, L., Abramowicz, D., Vereerstraeten, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006083422301 · Cited by 983
UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI )
Ortier, L. N., Arie, M., Chmeiser, H. S., Rlt, V. O. M. A., Ieler, H. A. B., Etein, M. I. P., Epierreux, M. I. F. D., Auw, L., Bramowicz, D. A. A., & Ereerstraeten, P. I. V. (2014) · Cited by 814
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
van Haaften, G., Dalgliesh, G. L., Davies, H., Chen, L., Bignell, G., Greenman, C., Edkins, S., Hardy, C., O'Meara, S., Teague, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.349 · Cited by 784
Self-citationExome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Wang, K., Kan, J., Yuen, S. T., Shi, S. T., Chu, K. M., Law, S., Chan, T. L., Kan, Z., Chan, A. S. Y., Tsui, W. Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.982 · Cited by 771
Aristolochic acid nephropathy: A worldwide problem
Debelle, F. D., Vanherweghem, J.-L., & Nortier, J. L. (2008) · Kidney International · doi:10.1038/ki.2008.129 · Cited by 763
Melanoma genome sequencing reveals frequent PREX2 mutations
Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature · doi:10.1038/nature11071 · Cited by 756
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., Wu, R., Chen, C., Li, X., Zhou, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.907 · Cited by 747
Zang, Z. J., Cutcutache, I., Poon, S. L., Zhang, S. L., McPherson, J. R., Tao, J., Rajasegaran, V., Heng, H. L., Deng, N., Gan, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2246 · Cited by 616
Self-citationAristolochic acid and the etiology of endemic (Balkan) nephropathy
Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701248104 · Cited by 606
Exome sequencing of liver fluke–associated cholangiocarcinoma
Ong, C. K., Subimerb, C., Pairojkul, C., Wongkham, S., Cutcutache, I., Yu, W., McPherson, J. R., Allen, G. E., Ng, C. C. Y., Wong, B. H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2273 · Cited by 486
Self-citationAristolochic acid-associated urothelial cancer in Taiwan
Chen, C.-H., Dickman, K. G., Moriya, M., Zavadil, J., Sidorenko, V. S., Edwards, K. L., Gnatenko, D. V., Wu, L., Turesky, R. J., Wu, X.-R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119920109 · Cited by 419
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Nikolaev, S. I., Rimoldi, D., Iseli, C., Valsesia, A., Robyr, D., Gehrig, C., Harshman, K., Guipponi, M., Bukach, O., Zoete, V., et al. (2012) · Nature Genetics · doi:10.1038/ng.1026 · Cited by 409
TFIIH: when transcription met DNA repair
Compe, E., & Egly, J.-M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3350 · Cited by 332
Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing
Hoang, M. L., Chen, C.-H., Sidorenko, V. S., He, J., Dickman, K. G., Yun, B. H., Moriya, M., Niknafs, N., Douville, C., Karchin, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006200 · Cited by 284
The 32P-postlabeling assay for DNA adducts
Phillips, D. H., & Arlt, V. M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.394 · Cited by 239
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
Jelaković, B., Karanović, S., Vuković-Lela, I., Miller, F., Edwards, K. L., Nikolić, J., Tomić, K., Slade, N., Brdar, B., Turesky, R. J., et al. (2012) · Kidney International · doi:10.1038/ki.2011.371 · Cited by 216
The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy: A Narrative Review
Gökmen, M. R., Cosyns, J.-P., Arlt, V. M., Stiborová, M., Phillips, D. H., Schmeiser, H. H., Simmonds, M. S. J., Cook, H. T., Vanherweghem, J.-L., Nortier, J. L., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-6-201303190-00006 · Cited by 182
Nonsense-Mediated RNA Decay Regulation by Cellular Stress: Implications for Tumorigenesis
Gardner, L. B. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0502 · Cited by 181
Whole-genome reconstruction and mutational signatures in gastric cancer
Nagarajan, N., Bertrand, D., Hillmer, A. M., Zang, Z. J., Yao, F., Jacques, P., Teo, A. S. M., Cutcutache, I., Zhang, Z., Lee, W., et al. (2012) · Genome biology · doi:10.1186/gb-2012-13-12-r115 · Cited by 156
Self-citationChen, C., Dickman, K. G., Huang, C., Moriya, M., Shun, C., Tai, H., Huang, K., Wang, S., Lee, Y., Grollman, A. P., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28013 · Cited by 131
Self-citationHerbal Medicine in Healthcare-An Overview
Mosihuzzaman, M. (2012) · Natural Product Communications · doi:10.1177/1934578x1200700628 · Cited by 129
Stiborová, M. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg119 · Cited by 116
Sidorenko, V. S., Yeo, J.-E., Bonala, R., Johnson, F., Schärer, O. D., & Grollman, A. P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1095 · Cited by 110
TP53 Mutational signature for aristolochic acid: an environmental carcinogen
Moriya, M., Slade, N., Brdar, B., Medverec, Z., Tomić, K., Jelaković, B., Wu, L., Truong, S., Fernandes, A., & Grollman, A. P. (2011) · International Journal of Cancer · doi:10.1002/ijc.26077 · Cited by 106
(2004) · PubMed · Cited by 102
Hollstein, M. C., Moriya, M., Grollman, A. P., & Olivier, M. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.02.003 · Cited by 69
Lukin, M., Zaliznyak, T., Johnson, F., & Santos, C. D. L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1094 · Cited by 47
Recognition of Damaged DNA: Structure and Dynamic Markers
Germann, M. W., Johnson, C. N., & Spring, A. M. (2010) · Medicinal Research Reviews · doi:10.1002/med.20226 · Cited by 39
On a nephrotoxic and carcinogenic slimming regimen
Broe, M. E. D. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70159-9 · Cited by 37
Nephropathy associated with use of a Chinese herbal product containing aristolochic acid
Chau, W., Ross, R., Li, J. Y. Z., Yong, T. Y., Klebe, S., & Barbara, J. A. J. (2011) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2011.tb03011.x · Cited by 35
Kwak, D. H., Lee, J., Kim, T., Ahn, H. S., Cho, W., Ha, H., Hwang, Y., & Yeul, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049530 · Cited by 34
Clinical and pathological spectrums of aristolochic acid nephropathy
Chen, D., Tang, Z., Chunlei, L., Chen, H., & Liu, Z. (2012) · Clinical Nephrology · doi:10.5414/cn107414 · Cited by 32
Cited by
The repertoire of mutational signatures in human cancer
Alexandrov, L. B., Kim, J., Haradhvala, N. J., Huang, M. N., Tian Ng, A. W., Wu, Y., Boot, A., Covington, K. R., Gordenin, D. A., Bergstrom, E. N., et al. (2020) · Nature · doi:10.1038/s41586-020-1943-3 · Cited by 3,496
Self-citationBurden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Gao, Q., Zhu, H., Dong, L., Shi, W., Chen, R., Song, Z., Huang, C., Li, J., Dong, X., Zhou, Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.052 · Cited by 1,096
Self-citation
Metadata
- Authors
- Poon, S. L., Pang, S.-T., McPherson, J. R., Yu, W., Huang, K. K., Guan, P., Weng, W.-H., Siew, E. Y., Liu, Y., Heng, H. L., Chong, S. C., Gan, A., Tay, S. T., Lim, W. K., Cutcutache, I., Huang, D., Ler, L. D., Nairismägi, M.-L., Lee, M. H., Chang, Y.-H., Yu, K.-J., Chan-on, W., Li, B.-K., Yuan, Y.-F., Qian, C.-N., Ng, K.-F., Wu, C.-F., Hsu, C.-L., Bunte, R. M., Stratton, M. R., Futreal, P. A., Sung, W.-K., Chuang, C.-K., Ong, C. K., Rozen, S. G., Tan, P., & Teh, B. T.
- Venue
- Science Translational Medicine
- Published
- 2013-08-07
- Volume
- 5
- Issue
- 197
- Pages
- 197ra101-197ra101
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2117785761
- Cited by
- 289
- References
- 41
- FWCI
- 23.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.